RESUMO
GTP cyclohydrolase I from human liver and Escherichia coli is competitively inhibited by 8-aminoguanosine triphosphate with a dissociation constant (Ki) of 0.25 mumol/l. 8-Aminoguanosine triphosphate, prepared from GTP and hydroxylamine-O-sulfonic acid, was coupled to Sepharose 4B and used as an affinity adsorbent for a 309-fold purification of GTP cyclohydrolase I from human liver. GTP cyclohydrolase I from human liver is a relatively heat-stable enzyme with a half-life of 2 min at 80 degrees C, an isoelectric point (pI) of about 5.6, and a Km for GTP of 31 mumol/l. Addition of KCl (0.3 mol/l) increased the Km to 153 mumol/l. No cofactors were required for activity. L-erythro-5,6,7,8-Tetrahydrobiopterin, L-erythro-7,8-dihydrobiopterin, L-sepiapterin and 8-aminoguanosine triphosphate were strong inhibitors.
Assuntos
Aminoidrolases/isolamento & purificação , GTP Cicloidrolase/isolamento & purificação , Guanosina Trifosfato/análogos & derivados , Fígado/enzimologia , Cromatografia de Afinidade/métodos , GTP Cicloidrolase/antagonistas & inibidores , Guanosina Trifosfato/síntese química , Guanosina Trifosfato/metabolismo , Guanosina Trifosfato/farmacologia , HumanosRESUMO
A deficiency of hepatic guanosine triphosphate cyclohydrolase I is reported in a 4-month-old infant in whom positive results on a Guthrie phenylketonuria test in the neonatal period were found. Because of the significantly elevated serum phenylalanine levels a diagnosis of classical phenylketonuria was made, and dietary therapy was started. Urinary pteridine screening for cofactor variants, however, revealed extremely low levels of both neopterin and biopterin. This suggested the possibility of guanosine triphosphate cyclohydrolase I deficiency and led to additional confirmatory assays. Repeat urine, serum, and CSF pteridine profiles, combined with tetrahydrobiopterin-loading studies and the assay of guanosine triphosphate cyclohydrolase I activity in a liver biopsy, confirmed the defect. It is significant to note that the diagnosis was made before the onset of major clinical symptoms. This case illustrates the need for routine cofactor variant screening of all infants in whom hyperphenylalaninemia is diagnosed in the neonatal period.
Assuntos
Aminoidrolases/deficiência , GTP Cicloidrolase/deficiência , Pteridinas/urina , Biopterinas/análogos & derivados , Biopterinas/metabolismo , Biopterinas/urina , Cromatografia Líquida de Alta Pressão , Diagnóstico Diferencial , GTP Cicloidrolase/metabolismo , Humanos , Recém-Nascido , Fígado/enzimologia , Masculino , Neopterina , Fenilalanina/sangue , Fenilalanina/metabolismo , Fenilcetonúrias/sangue , Fenilcetonúrias/diagnóstico , Pteridinas/metabolismoRESUMO
The biosynthetic pathway of tetrahydrobiopterin (BH(4)) from dihydroneopterin triphosphate (NH(2)P(3)) was studied in fresh as well as heat-treated human liver extracts. The question of NAD(P)H dependency for the formation of sepiapterin was examined. NH(2)P(3) was converted by fresh extracts to sepiapterin in low quantities (2% conversion) in the absence of exogenously added NADPH as well as under conditions that ensured the destruction of endogenous, free NAD(P)H. The addition of NADPH to the fresh liver extracts stimulated the synthesis of BH(4) to a much higher yield (17% conversion), and the amount of sepiapterin formed was reduced to barely detectable levels. In contrast, the heat-treated extract (enzyme A2 fraction) formed sepiapterin (1.3% conversion) only in the presence and not in the absence of NADPH. These results indicate that sepiapterin may not be an intermediate on the pathway leading to BH(4) biosynthesis under normal in vivo conditions. Rather, sepiapterin may result from the breakdown of an as yet unidentified intermediate that is actually on the pathway. It is speculated that NH(2)P(3) may be converted to a diketo-tetrahydropterin intermediate (or an equivalent tautomeric structure) by a mechanism involving an intramolecular oxidoreduction reaction. A diketo-tetrahydropterin intermediate could be converted to 5,6-dihydrosepiapterin, which also has a tetrahydropterin ring system and can be converted directly to BH(4) by sepiapterin reductase. This proposed pathway can explain ho the tetrahydropterin ring system can be formed without sepiapterin, dihydrobiopterin, or dihydrofolate reductase being involved in BH(4) biosynthesis in vivo .
RESUMO
A method for the qualitative analysis of oligopeptides in human urine in cases of peptiduria is described. After sample precleaning on a strongly acidic ion exchanger, the trifluoroacetyl/methyl esters were formed and the peptide derivatives were transformed into trifluoroethyl oligoamino alcohols according to Nau and Biemann. It was found that oligoamino alcohols could be isolated selectively on a weakly acidic ion exchanger. The O-trimethylsilylated trifluoroethyl oligoamino alcohols were separated on a SE-30 glass capillary column and analyzed by computer-assisted gas chromatography-mass spectrometry. In order to increase specificity and to facilitate mass spectrometric interpretation, aliquots of the sample were reduced separately with lithium-aluminium deuteride and hydride. Each peptide gave a pair of derivatives with characteristic mass differences of the ions, namely 2 mass units per reduced oxo group (deuterium-hydrogen-labelling of oxo groups by reduction). Correct identification is assumed only if both mass spectral patterns fit the theory. Sample volumes of 5--100 ml of urine are needed. About six samples can be derivatized per week. Three cases with suspected peptiduria were investigated and the following peptides were found: Gly-Pro-4Hyp-Gly; Gly-Pro-4Hyp; Gly-Hyp-Hyp (postulated isomer Gly-3Hyp-4Hyp); Pro-4Hyp and Gly-Pro. With exception of the tetrapeptide, these compounds could be detected also in the urine of a healthy child.
Assuntos
Oligopeptídeos/urina , Álcoois , Cromatografia Gasosa/métodos , Glicina , Humanos , Hidroxiprolina , Espectrometria de Massas/métodosRESUMO
An improved Chromotropic acid-sulfuric acid assay for urinary glycolic acid is described. The sample (0.5 ml or less) is precleaned by filtering through strongly acidic and strongly basic ion-exchangers and compared with a standard made up in normal urine. From the many compounds tested, only glyceric acid in pathologically high concentrations interfers partially; this interference can be recognized at 776 nm and eliminated by a second determination. Per man-day, 8--12 samples can be analyzed. Recovery of 0.8 mmol/l glycolic acid added to the urines of 12 persons was 100.6 +/- 4.7% (1 S.D., n=12) without, and 101.9 +/- 5.3% (1 S.D., n=12) with correction for isotope dilution of [1-14C]glycolic acid, respectively, using 0.5-ml sample volumes. The variation coefficients of a single determination were 1.5 and 2.1% without and with correction for isotope dilution, respectively (n=7). The method was checked by mass fragmentography. The following normal values were found in adults (n=15; x +/- 1 S.D. (range)): 47.3 +/- 10.1 (24.4--63.7) mmol/mol creatinine and 0.60 +/- 0.15 (0.29--0.91) mmol/day or 45.8 +/- 11.3 (22.2--69.0) mg/day. Two patients (F.G. and A.S.) with primary hyperoxaluria type I excreted glycolic acid between 112 and 379 mmol/mol creatinine and 1.21--5.64 mmol/day or 92--429 mg/day. Under vitamin B-6 treatment, urinary excretion decreased in one patient (F.G.) to 71--131 mmol/mol creatinine and 0.92--2.0 mmol/day or 70--152 mg/day.
Assuntos
Glicolatos/urina , Oxalatos/urina , Adulto , Colorimetria , Feminino , Humanos , Masculino , Métodos , NaftalenosRESUMO
An unknown compound present in the urine of a girl with prolonged transient tyrosinemia and her mother was isolated and identified as (2-L-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)-acetic acid (IVa). The new amino acid was named hawkinsin (Haw) and characterized by gas chromatography-mass spectrometry (GC-MS) of its penta-trimethylsilyl (TMS) derivative and of its desulfuration components. Haw was compared with the synthetic reference compound using GC-MS, IR, TLC, PC, ion-exchange chromatogrpahy and high-voltage electrophoresis. IVa and (2,6-bis-L-cystein-S-yl-1,4-dihydroxycyclohexyl-1)-acetic acid were synthesized from 4-quinolacetic acid, the latter was prepared in two different ways. It is postulated that Haw originates from an intermediate in the 4-hydroxy-phenylpuruvate hydroxylase reaction (EC 1.14.2.2), and that mother and child are heterozygous for an inborn error of metabolism characterized by a defect in this hydroxylase system, which is unable to rearrange the intermediate to homogentisic acid.
Assuntos
4-Hidroxifenilpiruvato Dioxigenase/deficiência , Erros Inatos do Metabolismo dos Aminoácidos/urina , Aminoácidos Sulfúricos/urina , Oxigenases/deficiência , Tirosina/metabolismo , Adulto , Cromatografia Gasosa , Cicloexenos , Feminino , Heterozigoto , Humanos , Lactente , Espectrometria de Massas , Espectrofotometria InfravermelhoRESUMO
An assay is described for GTP cyclohydrolase I activity in human mononuclear cells isolated from 20 ml of heparinized blood. The activity of this enzyme was low in unstimulated cells and increased 5-10 times after stimulation by phytohemagglutinin (formation of 0.8-1.3 pmol dihydroneopterin triphosphate/min per mg protein at 37 degrees C, n = 15) or mixed lymphocyte culture. No activity was detected in phytohemagglutinin-stimulated mononuclear cells of a patient with proven GTP cyclohydrolase I deficiency in liver; the samples from the father and mother of the patient showed 30 and 46%, respectively, of the mean of 15 healthy controls. In unstimulated cells, neopterin was the main component of the total intracellular pterins (after oxidation). After stimulation, dihydroneopterin triphosphate, measured as neopterin triphosphate by high performance liquid chromatography, was increased 10-30 times; neopterin and pterin were increased only 2- to 6-fold. Since the immunoreactive cells from this patient were unable to produce pterins and all immunological tests on the patient were normal, it is concluded that neither dihydroneopterin triphosphate, nor one of its metabolites are of primary importance for an immune reaction. The assay described can be used for the detection of heterozygotes of GTP cyclohydrolase I deficiency.
Assuntos
Aminoidrolases/sangue , GTP Cicloidrolase/sangue , Leucócitos/enzimologia , Feminino , GTP Cicloidrolase/deficiência , GTP Cicloidrolase/genética , Triagem de Portadores Genéticos , Humanos , Técnicas In Vitro , Teste de Cultura Mista de Linfócitos , Masculino , Fito-Hemaglutininas/farmacologia , Pterinas/sangueRESUMO
Isovaleryl-beta-D-glucuronide, a new metabolite in the urine of patients with isovaleric acidemia, is described. Its gas chromatographic and mass spectrometric parameters are presented. In alkaline solution this glucuronide exhibited intramolecular rearrangements, resulting in isomers bearing the acyl moiety on C-2, C-3 and C-4. The isomers showed similar mass spectra but different positions on the gas chromatogram. In the index patient isovalerylglucuronide was a main metabolite, but the excretion was a transient phenomenon. Only traces of isovalerylglucuronide could also be detected in the urine of three other patients with isovaleric acidemia. The significance of this metabolite for the detoxication of isovalerate in isovaleric acidemia is discussed.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/urina , Glucuronatos/urina , Ácidos Pentanoicos/sangue , Valeratos/sangue , Valeratos/urina , Cromatografia Gasosa/métodos , Hemiterpenos , Humanos , Concentração de Íons de HidrogênioRESUMO
Two regulation systems of the serotonin and dopamine biosynthesis in patients with classical and atypical PKU were investigated. In classical PKU, the serotonin and dopamine biosynthesis is inhibited by high L-phenylalanine in blood and tissues. The dopamine formation in vivo was inhibited by phenylalanine blood concentrations higher than 25 mg/dl: the serotonin formation was inhibited even at a phenylalanine blood concentration of only 8 mg/dl. In two patients with dihydrobiopterin synthetase deficiency, the dopamine, and even more pronounced the serotonin, excretions are considerably reduced. The dopamine excretion was reduced to about 50% and the serotonin excretion to only 10% compared to controls. Under BH4 therapy (16 mg daily), the dopamine values increased about twice, serotonin threefold and the phenylalanine blood concentration normalized to 1-1.5 mg/dl. On loading a patient with BH2 synthetase deficiency with 50 mg/kg deuterated tryptophan-d5 and 150 mg/kg deuterated tyrosine d2 (phenylalanine blood concentration of 16 mg/dl), deuterated dopamine d1 and serotonin d4 could only be formed in detectable amounts after BH4 administration. During BH4 therapy the amount of dopamine d1 and serotonin d4 formed was lower than but comparable to normal controls.
Assuntos
Dopamina/biossíntese , Fenilcetonúrias/metabolismo , Serotonina/biossíntese , Humanos , Cinética , Fenilalanina/sangue , Serotonina/metabolismo , Triptaminas/metabolismo , Triptofano Hidroxilase/antagonistas & inibidores , Tirosina/metabolismo , Tirosina 3-Mono-Oxigenase/antagonistas & inibidoresAssuntos
Teste de FIGLU , Ácido Fólico/sangue , Administração Oral , Adulto , Amidas/urina , Pré-Escolar , Cromatografia por Troca Iônica , Creatinina/metabolismo , Eletroforese em Papel , Feminino , Ácido Fólico/administração & dosagem , Ácido Fólico/farmacologia , Seguimentos , Formiatos/urina , Glutamatos/urina , Glicina/farmacologia , Hemoglobinas , Histidina/farmacologia , Humanos , Imidazóis/urina , Iminas/urina , Testes de Inteligência , Masculino , Espectrometria de Massas , Linhagem , Serina/farmacologia , TransferasesAssuntos
Fenilcetonúrias/enzimologia , Pterinas/deficiência , Adolescente , Adulto , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Fenilalanina/sangue , Fenilcetonúrias/diagnóstico , Fenilcetonúrias/tratamento farmacológico , Pterinas/uso terapêutico , Pterinas/urinaAssuntos
Antiparkinsonianos , Biopterinas/uso terapêutico , Doença de Parkinson/tratamento farmacológico , Pteridinas/uso terapêutico , Idoso , Antidepressivos , Biopterinas/análogos & derivados , Encéfalo/enzimologia , Transtorno Depressivo/tratamento farmacológico , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/enzimologia , Fenilalanina Hidroxilase/metabolismo , Fenilcetonúrias/tratamento farmacológicoAssuntos
Síndrome de Lesch-Nyhan/metabolismo , Automutilação/etiologia , Adenina Fosforribosiltransferase/metabolismo , Eritrócitos/enzimologia , Feminino , Fibroblastos/enzimologia , Humanos , Hipoxantina Fosforribosiltransferase/metabolismo , Lactente , Síndrome de Lesch-Nyhan/imunologia , Síndrome de Lesch-Nyhan/psicologia , Masculino , Pterinas/urinaAssuntos
Fenilalanina/sangue , Pterinas/deficiência , Feminino , Humanos , Recém-Nascido , Pterinas/biossínteseRESUMO
The occurrence, properties and functions of GTP-cyclohydrolases in mammalian and non-mammalian systems is reviewed. GTP-cyclohydrolases catalyse the removal of C-8 atom from GTP as formic acid. GTP-cyclohydrolase I (EC 3.5.4.16) converts GTP into D-erythro-7, 8-dihydroneopterin triphosphate, whereas GTP-cyclohydrolase II forms 2,5-diamino-4-oxo-6-(5'-phosphoribosyl) -amino pyrimidine, a possible intermediate in the biosynthesis of riboflavin. GTP-cyclohydrolase I is the first enzyme in the biosynthesis of tetrahydrobiopterin, a cofactor of the monooxygenases of the aromatic amino acids. It is the rate limiting enzyme in many mammals, but not in man. Recently, patients with GTP -cyclohydrolase I deficiency were described, a variant form of tetrahydrobiopterin-deficient hyperphenylalaninaemia.